The University of Chicago Header Logo

Connection

Nishant Agrawal to Cell Line, Tumor

This is a "connection" page, showing publications Nishant Agrawal has written about Cell Line, Tumor.
Connection Strength

0.151
  1. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004 Oct 19; 101(42):15172-7.
    View in: PubMed
    Score: 0.042
  2. Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma. Oral Oncol. 2024 Feb; 149:106688.
    View in: PubMed
    Score: 0.039
  3. Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas. Cancer Res. 2019 08 15; 79(16):4026-4041.
    View in: PubMed
    Score: 0.029
  4. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics. 2014 Jul; 9(7):1031-46.
    View in: PubMed
    Score: 0.020
  5. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 2005 Jul; 7(7):665-74.
    View in: PubMed
    Score: 0.011
  6. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A. 2003 Dec 09; 100(25):15083-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.